Filter
316
Text search:
synthetic
drugs
Featured
Recommendations
31
New Publications
82
Language
Document type
No document type
177
Guidelines
61
Studies & Reports
47
Manuals
13
Strategic & Response Plan
10
Training Material
3
Situation Updates
3
Resource Platforms
1
Fact sheets
1
Countries / Regions
India
30
South Africa
13
Global
12
Western and Central Europe
11
Nigeria
9
Ethiopia
8
Kenya
8
Nepal
5
Uganda
4
Rwanda
4
Bangladesh
4
Ukraine
4
Latin America and the Carribbean
4
Zimbabwe
3
Tanzania
3
Namibia
3
Eastern Europe
3
Sierra Leone
2
Liberia
2
Ghana
2
Philippines
2
Zambia
2
North Macedonia
2
Botswana
2
Eastern Europe and Central Asia
2
Russia
2
Moldova
2
USA
1
Somalia
1
Pakistan
1
South Sudan
1
Afghanistan
1
Syria
1
Eswatini/ Swaziland
1
Brazil
1
Serbia
1
Libya
1
Lesotho
1
Myanmar / Burma
1
Africa
1
Solomon Islands
1
Southern Africa
1
Canada
1
Tajikistan
1
Vietnam
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
119
Clinical Guidelines
24
Public Health
12
Women & Child Health
11
Pharmacy & Technologies
8
Key Resources
3
Capacity Building
1
Toolboxes
Mental Health
62
AMR
35
Pharmacy
29
HIV
14
NTDs
9
COVID-19
8
Planetary Health
8
Ebola
6
TB
6
Rapid Response
5
Disability
4
Conflict
4
Refugee
4
Caregiver
3
NCDs
3
Specific Hazards
2
Global Health Education
2
Health Financing Toolbox
2
Cholera
1
Polio
1
Zika
1
Biodiversity and healthy natural ecosystems, including protected areas in and around cities, provide ecosystem benefits and services that support human health, including reducing flood risk, filtering air pollutants, and providing a reliable supply of clean drinking water. These services help to red
...
The Global guidance framework for the responsible use of the life sciences: mitigating biorisks and governing dual-use research (the framework) aims to provide values and principles, tools and mechanisms to support Member States and key stakeholders to mitigate and prevent biorisks and govern dual-u
...
Canadian Journal of Microbiology 25 June 2021 https://doi.org/10.1139/cjm-2020-0572
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t
...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f
...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
The Pharmaceutical Forum of the Americas (PFA) has previously published guidelines and organised campaigns for community pharmacists on the prevention, detection and control of arbovirus infections in 2018 with a grant from the FIP Foundation for Pharmacy Education and Research. Building on that exp
...
Multiple pandemics, numerous outbreaks, thousands of lives lost and billions of dollars of national income wiped out—all since the turn of this century, in barely 17 years—and yet the world’s investments in pandemic preparedness and response remain woefully inadequate. We know by now that the
...
Many features of the environment have been found to exert an important influence on cardiovascular disease (CVD) risk, progression, and severity. Changes in the environment due to migration to different geographic locations, modifications in lifestyle choices, and shifts in social policies and cultu
...
The Infection Prevention and Control (IPC) Guidelines aim to support healthcare workers improve quality and safety health care. The Guidelines further aim to promote and facilitate the overall goal of IPC by providing evidence-based recommendations on the critical aspects of IPC, focusing on the fun
...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im
...
with recommended essential medicines for common diseases in patients in Stockholm County Council (Healthcare Region), Sweden
Menthol in tobacco products
